Silence Therapeutics Cash Flow Statement (2019-2025) | SLN

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2019 Dec2019 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -12.31M-17.39M-13.61M-17.76M-16.61M-15.13M-12.84M-16.90M-10.99M-17.65M-15.40M-15.03M-13.50M-18.58M-2.31M-19.75M-35.54M12.30M-28.53M-27.35M-20.96M
Depreciation and Depletion 0.12M0.24M0.17M0.16M0.15M0.09M0.15M0.14M0.13M0.17M0.14M0.15M0.15M0.14M0.09M0.09M0.09M0.08M0.07M0.08M0.08M
Share-based Compensation 4.02M2.05M3.80M3.56M2.48M4.13M3.85M2.82M2.02M5.71M3.75M4.88M1.87M4.12M4.14M4.07M3.98M3.54M2.08M2.54M
Deferred Taxes 0.24M0.23M0.05M0.32M0.01M0.00M
Gains from Sales and Divestitures 0.00M0.00M-0.00M0.10M
Gains from Investment Securities 13.57M19.68M-0.11M-0.17M-0.28M7.36M-0.09M-0.42M-2.89M
Non-cash Items 2.22M3.00M29.10M3.41M3.71M3.98M
Cash from Operations -8.01M-11.12M-16.68M36.38M-6.79M-2.97M-19.29M-10.41M-11.08M-15.73M-9.31M-18.72M-6.17M-22.44M-9.14M-5.41M-25.61M-27.48M-12.31M-21.79M-10.90M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.01M0.01M0.01M0.01M0.01M0.00M0.00M0.00M0.00M0.02M0.00M0.01M0.01M0.06M0.06M0.07M0.06M0.07M0.07M0.07M
Depreciation & Amortization (CF) 0.12M0.24M0.17M0.16M0.15M0.09M0.15M0.14M0.13M0.17M0.14M0.15M0.15M0.14M0.09M0.09M0.09M0.08M0.07M0.08M0.08M
Change in Working Capital
Change in Receivables 0.60M-2.46M3.27M-0.92M-0.95M0.81M0.27M0.29M10.01M-7.97M-1.75M0.61M-0.94M0.01M-0.06M
Change in Account Payables 1.83M-2.70M
Change in Taxes 596.21M-3642.47M1,999.44M1.51M2.93M2.53M1.87M2.62M3.00M2.01M3.05M1.89M2.37M4.09M
Other Working Capital Changes 1.00M1.14M2.57M6.10M5.04M3.97M7.44M8.33M10.47M12.19M11.43M10.19M8.47M14.34M11.34M-5.51M1.57M-0.68M-24.16M0.59M-3.02M-5.33M
Investing Activities
Capital Expenditures 0.09M0.06M0.06M0.00M0.05M0.00M
Cash from Investing Activities 12.91M26.37M-0.02M-0.61M6.44M6.00M-0.07M-0.04M-0.05M-19.25M0.16M-5.89M26.13M0.47M-49.91M-0.04M-38.14M66.12M-44.38M-1.56M51.29M
Financing Activities
Other financing activities 357.14M
Cash from Financing Activities -0.14M41.85M-0.09M0.59M-0.06M-0.01M50.75M0.05M0.02M3.98M15.24M12.31M133.02M1.19M7.97M-0.10M0.01M0.00M
Additional items
Exchange Rate Effect -0.26M0.57M0.05M-0.03M-0.47M-0.72M0.31M0.74M5.70M0.49M-0.70M-0.66M1.65M-0.21M-0.04M-0.01M0.27M-0.16M0.23M0.20M-0.11M
Change in Cash 4.90M19.09M25.15M35.69M0.24M3.03M-19.42M-10.47M39.62M-34.93M-9.13M-20.62M35.20M-1.94M73.97M-4.26M-55.77M38.55M-56.68M-23.34M40.40M
Beginning Cash Balance 14.81M17.38M12.82M13.06M17.16M37.90M63.88M98.29M96.10M98.99M75.41M66.47M99.22M65.93M57.81M39.30M70.73M69.44M142.45M136.27M82.78M193.18M137.54M61.80M
Free Cash Flow -8.01M-11.12M-16.68M36.38M-6.79M-2.97M-19.29M-10.41M-11.08M-15.73M-9.31M-18.72M-6.17M-22.44M-9.14M-5.49M-25.67M-27.54M-12.31M-21.84M-10.90M
Net Cash Flow 4.90M15.10M25.15M35.69M0.24M3.03M-19.42M-10.47M39.62M-34.93M-9.13M-20.62M35.20M-9.65M73.97M-4.26M-55.77M38.55M-56.68M-23.35M40.39M